Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - May 12, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing tec
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-12 7:00 AM EDT | Phio Pharmaceuticals Corp.
Herbal Dispatch Expands House of Brands Strategy with Launch of Northern Drip Extracts
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") is pleased to announce the launch of its new mid-to-premium cannabis extracts brand, Northern Drip, expanding the Company's presence in one of the fastest-growing segments of the Canadian cannabis market.Northern Drip represents Herbal Dispatch's fifth in-house brand launch, joining the Company
Pharmaceuticals, Cannabis, Cannabis Dispensary
2026-05-12 3:01 AM EDT | Herbal Dispatch Inc.
Telescope Innovations Shares Spring 2026 Conference and Events Lineup
Vancouver, British Columbia--(Newsfile Corp. - May 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities, both past and planned for spring 2026. Our participation includes presentations, exhibitions and keynote lect
Technology, Chemical, Pharmaceuticals
2026-05-11 8:00 AM EDT | Telescope Innovations Corp.
Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
Encinitas, California--(Newsfile Corp. - May 8, 2026) - Kiora Pharmaceuticals (NASDAQ: KPRX) today reported financial results for the first quarter ended March 31, 2026, and provided an update on its clinical pipeline of small molecules for the treatment of retinal diseases. First Quarter 2026 and Recent Highlights Enrollment in the Phase 2 ABACUS-2 study of KIO-301 remains very active, with expansion of clinical trial sites to accommodat
Biotechnology, Pharmaceuticals
2026-05-08 7:00 AM EDT | Kiora Pharmaceuticals, Inc.
Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
King of Prussia, Pennsylvania--(Newsfile Corp. - May 7, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio today reported its financial results for the quarter ended March 31, 2026, and provided a busine
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-07 4:05 PM EDT | Phio Pharmaceuticals Corp.
Herbal Dispatch Reports Accelerating Veteran Customer Growth and Expansion of Insurance-Focused Service Channel
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), is pleased to provide an update on the continued growth and expansion of its veteran-focused medical cannabis channel. The Company has experienced sustained acceleration in veteran customer acquisition, driven by targeted outreach, streamlined onboarding, and a dedicated service model tailored to the
Pharmaceuticals, Cannabis, Cannabis Dispensary
2026-05-07 7:00 AM EDT | Herbal Dispatch Inc.
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reports financial results for the third quarter of the fiscal year 2026 which ended March 31, 2026. The Company's full financial statements and related MD&A for the third
Biotechnology, Pharmaceuticals
2026-05-06 6:00 PM EDT | InMed Pharmaceuticals
Nextleaf Reports AGM Results and Expands Industry Leadership Through CCBC
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor announces the results of its annual general meeting of shareholders (the "Meeting") held on April 30, 2026, in Vancouver, British Columbia, and provides an update on its continued engagement in industry advocacy initiatives supporting the advancement of B
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2026-05-06 9:00 AM EDT | Nextleaf Solutions Ltd.
Theralase(R) Announces $4 Million Brokered LIFE Offering
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and v
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-05-05 7:10 PM EDT | Theralase Technologies Inc.
Herbal Dispatch Launches Next-Generation E-Commerce Platform, Targeting High-Growth $245 Million Insured Medical Cannabis Segment
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution platform, is pleased to announce the launch of the upgraded HeroDispatch.com, alongside significant enhancements to HerbalDispatch.com for standard medical patients. These upgraded platforms are designed to position Herbal Dispatch as a preferred partner for bot
Pharmaceuticals, Cannabis, Cannabis Dispensary
2026-05-05 3:01 AM EDT | Herbal Dispatch Inc.
Bachem Announces Changes to the Corporate Executive Committee
Bubendorf, Switzerland--(Newsfile Corp. - May 5, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) today announced that Torsten Wöhr, Chief Commercial Officer, has decided to pursue a new opportunity outside the company. Until a successor will be appointed, Anne-Kathrin Stoller will assume the role of Chief Commercial Officer in addition to her responsibilities as Chief Executive Officer (CEO), effective May 25, 2026. “Torsten Wöhr
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-05-05 1:08 AM EDT | Bachem Holding AG
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancer, bacteria and viruses has released the Company's audited consolidated financial statements for the twelve-month period ended December 31
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-05-04 5:22 PM EDT | Theralase Technologies Inc.
Richards Group Inc. Announces 2026 First Quarter Results
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today results for the quarter ended March 31, 2026. "The first quarter of 2026 saw a few important milestones in our long-term strategic plan. We launched a series of new OEM products under the DermapenWorld brand, grew significantly across our healthcare distribution verticals, and continued packaging modernization with ecommerce fulfillment site launches and the go-live of
Healthcare and Hospitals, Household / Consumer / Cosmetics, Pharmaceuticals
2026-05-04 7:00 AM EDT | Richards Group Inc.
Richards Group Inc. Announces Election of Directors
Mississauga, Ontario--(Newsfile Corp. - May 1, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced that the six nominees listed in the management information circular for the 2026 Annual Meeting of Shareholders were elected as Directors of the Company at the annual general meeting held in Mississauga, Ontario on May 1, 2026. Detailed results of the vote for the election of directors held at the meeting are set out below:
Healthcare and Hospitals, Household / Consumer / Cosmetics, Pharmaceuticals
2026-05-01 5:34 PM EDT | Richards Group Inc.
United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation
Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. United Dogecoin will be merged into a wholly owned subsidiary of Shuttle. The merger is supported by a $11 million concurrent Private Investment in Public Equity ("PIPE") financing expected to close on Ma
2026-05-01 8:41 AM EDT | Shuttle Pharmaceuticals Holdings Inc.
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, announces that it has filed on SEDAR+ and completed the mailing of its notice of annual and special meeting, management information circular and related meeting materials (collectively, the "Mee
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-05-01 8:04 AM EDT | Neural Therapeutics Inc.
Richards Group Inc. Announces Acquisition of the CPG Assets of PharmaSystems Inc.
Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announces today an acquisition to add to its healthcare line up. Effective May 1, 2026, the Company, through its subsidiary, Healthmark Services Ltd., is acquiring the assets of PharmaSystems Inc.'s consumer packaged goods division ("PSI CPG"), a leading provider of essential over-the-counter health and wellness products to major pharmacies and retailers across Canada. The purchase pr
Healthcare and Hospitals, Household / Consumer / Cosmetics, Pharmaceuticals
2026-04-30 6:00 PM EDT | Richards Group Inc.
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its first quarter 2026 financial results before the market opening on Thursday, May 14, 2026. The Company will also host a conference call and webcast at 8:00 a.m. U.S. Eastern Time to discuss the results and provide
Biotechnology, Pharmaceuticals, Health
2026-04-30 4:05 PM EDT | BioHarvest Sciences Inc.
Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner
Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. United Dogecoin will be merged into a wholly owned subsidiary of Shuttle. The merger is supported by a $11 million concurrent Private Investment in Public Equity ("PIPE") financing expected to close on
2026-04-30 4:05 PM EDT | Shuttle Pharmaceuticals Holdings Inc.
Herbal Dispatch Completes First International Gummy Export, Generates $350,000 in Revenue and Advances Global Edibles Strategy
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), today announces the successful completion of its first export of medical cannabis gummies to Australia, generating approximately $350,000 in revenue and marking a significant milestone in the Company's international growth strategy. The export reflects accelerating global demand for regulated cann
Pharmaceuticals, Cannabis, Cannabis Dispensary
2026-04-30 8:00 AM EDT | Herbal Dispatch Inc.